Rani Therapeutics to Participate in Upcoming Investor Conferences
08 11월 2024 - 6:05AM
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”)
(Nasdaq: RANI), a clinical-stage biotherapeutics company focused on
the oral delivery of biologics and drugs, today announced that the
company’s management team will participate in three upcoming
conferences. These conferences include:
UBS Global Healthcare
Conference Location: Terranea Resort,
Rancho Palos Verdes, CADate: Thursday, November
14, 2024 at 10:15am PTFormat: Fireside Chat and
1x1 Meetings
Stifel Healthcare Conference
Location: Lotte New York Palace Hotel, New York,
NYDate: Monday, November 18, 2024 at 4:10pm ET Format: Fireside
Chat and 1x1 Meetings
7th Annual Evercore ISI HealthCONx
ConferenceLocation: The Loews Coral
Gables Hotel, Coral Gables, FL Date: Wednesday,
December 4, 2024 at 12:55pm ETFormat: Fireside
Chat and 1x1 Meetings
Interested parties can register for and access
the live webcasts for these conferences by visiting the “Events”
section of the Rani Therapeutics website. The webcast replays will
be available after the conclusion of the respective
presentations.
About Rani TherapeuticsRani
Therapeutics is a clinical-stage biotherapeutics company focused on
advancing technologies to enable the development of orally
administered biologics and drugs. Rani has developed the RaniPill®
capsule, which is a novel, proprietary and patented platform
technology, intended to replace subcutaneous injection or
intravenous infusion of biologics and drugs with oral dosing. Rani
has successfully conducted several preclinical and clinical studies
to evaluate safety, tolerability and bioavailability using
RaniPill® capsule technology. For more information, visit
ranitherapeutics.com.
Investor
Contact:investors@ranitherapeutics.com
Media
Contact:media@ranitherapeutics.com
Rani Therapeutics (NASDAQ:RANI)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Rani Therapeutics (NASDAQ:RANI)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024